Our Leadership Team

Dean Park, CEO

Dean Park is the Founder of Mezzion Pharma Co. Ltd. and also serves as the Chief Executive Officer. Dean has also founded and served as Chief Executive Officer and/or President for a number of other successful international companies, including AIA Capital Korea, Far East Investment, Hutchison Corporate Access and Ricco Nine. Dean has previously served as Vice President and Director of the investment banking group at Merrill Lynch Capital Markets.

John Presser leads global business development, commercial strategy, and external affairs at Mezzion. He plays a key role in aligning late-stage R&D with launch execution, while expanding the company’s rare disease pipeline and strategic partnerships. Prior to Mezzion, he spent nearly 20 years at Boehringer Ingelheim, where he led the largest U.S. payer portfolio and supported the launch of 30+ products, including 10 global blockbusters. He began his career in R&D at Amylin Pharmaceuticals and The Salk Institute.